investigating the pathogenesis, aetiology and epidemiology of neurodegenerative diseases such as Parkinson's disease • influence of complex interactions between genetic and environmental factors in relation to disease risk

• Parkinson’s disease Drug Discovery

The Clinical Neuroscience program is a multidisciplinary collaboration that combines clinical and population-based research with laboratory-based cellular and molecular techniques to explore the causes of neurological diseases. The group has several focus areas including; • the epidemiology of Parkinson's disease; • the genetics of parkinsonism and related disorders; • interactions between genetic and environmental factors and the genetic epidemiology of complex traits; • preclinical drug discovery science including target identification and discovery of new drugs and probe molecules; • clinical trials of novel treatments for Parkinson's disease and related disorders.